Celldex Therapeutics CLDX
$27.42 −$0.54 (-1.93%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $27.40 -0.07%
Open$27.01
Prev close$27.96
Day range$26.64 – $28.43
Volume1.72M
Market cap$2.15B
P/E (TTM)–
Dividend yield–
CLDX Stock News
Headlines matching Celldex Therapeutics or the CLDX ticker, most recent first.
- LifeSci Capital Maintains Celldex Therapeutics(CLDX.US) With Buy Rating, Raises Target Price to $64 Positive
- Morgan Stanley Maintains Celldex Therapeutics(CLDX.US) With Buy Rating, Maintains Target Price $57
- A Quick Look at Today's Ratings for Celldex Therapeutics(CLDX.US), With a Forecast Between $50 to $88
- Leerink Partners Maintains Outperform on Celldex Therapeutics, Raises Price Target to $88 Positive
- Celldex Therapeutics Is Maintained at Overweight by Morgan Stanley
- A Quick Look at Today's Ratings for Celldex Therapeutics(CLDX.US), With a Forecast Between $50 to $100
- Celldex Therapeutics Is Maintained at Outperform by Leerink Partners Positive
- Celldex Therapeutics Price Target Raised to $88.00/Share From $70.00 by Leerink Partners Positive
- Analysts' Opinions Are Mixed on These Healthcare Stocks: Owlet (OWLT), Celldex (CLDX) and Edgewise Therapeutics (EWTX)
- Celldex Therapeutics | 8-K: Current report
- LifeSci Capital Maintains Celldex Therapeutics(CLDX.US) With Buy Rating, Maintains Target Price $56
- Morgan Stanley Maintains Celldex Therapeutics(CLDX.US) With Buy Rating, Raises Target Price to $50 Positive
- A Quick Look at Today's Ratings for Celldex Therapeutics(CLDX.US), With a Forecast Between $42 to $56
- 10-Q: Celldex Therapeutics | 10-Q: Q2 2026 Earnings Report
- A Quick Look at Today's Ratings for Celldex Therapeutics(CLDX.US), With a Forecast Between $42 to $100
No comments yet — be the first to weigh in on CLDX.
Sign in to join the discussion.